Effects of estrogenic chemicals on development.

por Jones, L A, Hajek, R A
Publicado 1995

Fibrinolysis during cardiopulmonary bypass detected with thromboelastography

por Hájek, R, Ružičková, J, Fluger, I, Nemec, P, Bruk, V
Publicado 2007

It's time to rethink dose: the case for combining cancer and birth and developmental defects.

por Axelrod, D, Davis, D L, Hajek, R A, Jones, L A
Publicado 2001

Endothelial protein C receptor expression after cardiopulmonary bypass in adult cardiac surgical patients

por Hajek, R, Ruzickova, J, Slavik, L, Krcova, V, Simek, M, Fluger, I
Publicado 2010

Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target?

por Steiner, N., Hajek, R., Nachbaur, D., Borjan, B., Sevcikova, S., Göbel, G., Gunsilius, E.
Publicado 2019

Current applications of multiparameter flow cytometry in plasma cell disorders

por Jelinek, T, Bezdekova, R, Zatopkova, M, Burgos, L, Simicek, M, Sevcikova, T, Paiva, B, Hajek, R
Publicado 2017

Current applications of multiparameter flow cytometry in plasma cell disorders

por Jelinek, T, Bezdekova, R, Zatopkova, M, Burgos, L, Simicek, M, Sevcikova, T, Paiva, B, Hajek, R
Publicado 2018

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies

por Ševčíková, T, Growková, K, Kufová, Z, Filipová, J, Vrublová, P, Jelínek, T, Kořístek, Z, Kryukov, F, Kryukova, E, Hájek, R
Publicado 2017

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data

por Campioni, M., Agirrezabal, I., Hajek, R., Minarik, J., Pour, L., Spicka, I., Gonzalez-McQuire, S., Jandova, P., Maisnar, V.
Publicado 2019

P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY DRUG...

por Mateos, M, Szarejko, M, Bila, J, Schjesvold, F, Spicka, I, Maisnar, V, Jurczyszyn, A, Grudeva-Popova, Z, Hajek, R, Usenko, G, Thuresson, M, Norin, S, Jarefors, S, Richardson, P, Pour, L
Publicado 2023

Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes

por Hari, P, Mateos, M-V, Abonour, R, Knop, S, Bensinger, W, Ludwig, H, Song, K, Hajek, R, Moreau, P, Siegel, D S, Feng, S, Obreja, M, Aggarwal, S K, Iskander, K, Goldschmidt, H
Publicado 2017

P967: TUMOR BURDEN AS A CRITICAL PROGNOSTIC FACTOR OF PRIMARY EXTRAMEDULLARY DISEASE

por Vlachová, M., Štork, M., Ševčíková, S., Jelínek, T., Minařík, J., Radocha, J., Krhovská, P., Pospíšilová, L., Špička, I., Straub, J., Pavlíček, P., Jungová, A., Sandecká, V., Maisnar, V., Hájek, R., Pour, L.
Publicado 2022

During development, 17alpha-estradiol is a potent estrogen and carcinogen.

por Hajek, R A, Robertson, A D, Johnston, D A, Van, N T, Tcholakian, R K, Wagner, L A, Conti, C J, Meistrich, M L, Contreras, N, Edwards, C L, Jones, L A
Publicado 1997

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment

por Dimopoulos, M A, Stewart, A K, Masszi, T, Špička, I, Oriol, A, Hájek, R, Rosiñol, L, Siegel, D, Mihaylov, G G, Goranova-Marinova, V, Rajnics, P, Suvorov, A, Niesvizky, R, Jakubowiak, A, San-Miguel, J, Ludwig, H, Ro, S, Aggarwal, S, Moreau, P, Palumbo, A
Publicado 2017

P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY

por Trněný, M., Fogliatto, L., Gardner, F., Flinn, I., Larouche, J.-F., Haioun, C., Canales, M., Goto, H., Hajek, R., Salles, G., Qiu, J., Campinha-Bacote, A., Yan, M., Kothari, R., Man, G., Sahin, D., Hirata, J., Lee, C., Tilly, H., Flowers, C.
Publicado 2022

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

por Moreau, P, Joshua, D, Chng, W-J, Palumbo, A, Goldschmidt, H, Hájek, R, Facon, T, Ludwig, H, Pour, L, Niesvizky, R, Oriol, A, Rosiñol, L, Suvorov, A, Gaidano, G, Pika, T, Weisel, K, Goranova-Marinova, V, Gillenwater, H H, Mohamed, N, Aggarwal, S, Feng, S, Dimopoulos, M A
Publicado 2017

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

por Chng, W-J, Goldschmidt, H, Dimopoulos, M A, Moreau, P, Joshua, D, Palumbo, A, Facon, T, Ludwig, H, Pour, L, Niesvizky, R, Oriol, A, Rosiñol, L, Suvorov, A, Gaidano, G, Pika, T, Weisel, K, Goranova-Marinova, V, Gillenwater, H H, Mohamed, N, Feng, S, Aggarwal, S, Hájek, R
Publicado 2017

P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE

por Jaccard, A., Bridoux, F., Roeloffzen, W., Minnema, M. C., Bergantim, R., Hájek, R., João, C., Cibeira, M. T., Palladini, G., Schönland, S., Merlini, G., Milani, P., Dimopoulos, M. A., Ravichandran, S., Hegenbart, U., Agis, H., Gros, B., Asra, A., Dergarabetian, E., Magarotto, V., Leonidakis, A., Cheliotis, G., Sonneveld, P., Wechalekar, A., Kastritis, E.
Publicado 2022

B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS

por Musto, P., Minnema, M.C., Roeloffzen, W.W.H., Capra, A., van der Holt, B., Juul Vangsted, A., Broyl, A., Schjesvold, F., Lund, T., Silkjaer, T., Benjamin, R., Grasso, M., Lung Wu, K., Caers, J., Cavo, M., Hájek, R., Bruno, B., Gadisseur, A., Pietrantuono, G., Offidani, M., Pour, L., Sonneveld, P., Boccadoro, M., van de Donk, N.
Publicado 2023

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR...

por van de Donk, N., Minnema, M.C., van der Holt, B., Schjesvold, F., Wu, K.L., Capra, A., Broyl, A., Roeloffzen, W.W.H., Gadisseur, A.P.A., Pietrantuono, G., Pour, L., van der Velden, V., Lund, T., Offidani, M., Grasso, M., Giaccone, L., Cavo, M., Silkjaer, T., Caers, J., Zweegman, S., Hajek, R., Benjamin, R., Vangsted, A., Boccadoro, M., Gay, F., Sonneveld, P., Musto, P.
Publicado 2023